Warning: The NCBI web site requires JavaScript to function. more...
Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK, Schiemann WP.
Breast Cancer Res. 2009;11(5):R68. Epub .
Related citations
Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Wendt MK, Smith JA, Schiemann WP.
Oncogene. 2010 Dec 9;29(49):6485-98. Epub 2010 Aug 30.
Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Galliher AJ, Schiemann WP.
Cancer Res. 2007 Apr 15;67(8):3752-8.
Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Breast Cancer Res. 2006;8(4):R42.
Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta.
Galliher-Beckley AJ, Schiemann WP.
Carcinogenesis. 2008 Feb;29(2):244-51. Epub 2008 Jan 3.
Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms.
Walsh MF, Ampasala DR, Hatfield J, Vander Heide R, Suer S, Rishi AK, Basson MD.
Am J Pathol. 2008 Aug;173(2):385-99. Epub 2008 Jun 26.
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N, Chytil A, Shyr Y, Joly A, Moses HL.
Mol Cancer Res. 2008 Oct;6(10):1521-33.
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cancer Res. 2007 May 15;67(10):4869-77. Epub 2007 May 10.
Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL.
J Biol Chem. 2001 Dec 14;276(50):46707-13. Epub 2001 Oct 5.
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
Cancer Res. 2004 Aug 1;64(15):5200-11.
Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
Maeda M, Shintani Y, Wheelock MJ, Johnson KR.
J Biol Chem. 2006 Jan 6;281(1):59-68. Epub 2005 Nov 1.
Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.
Ehata S, Hanyu A, Hayashi M, Aburatani H, Kato Y, Fujime M, Saitoh M, Miyazawa K, Imamura T, Miyazono K.
Cancer Res. 2007 Oct 15;67(20):9694-703.
p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
J Biol Chem. 2009 Dec 4;284(49):34145-56. Epub 2009 Oct 12.
TGF-beta 1 modulated the expression of alpha 5 beta 1 integrin and integrin-mediated signaling in human hepatocarcinoma cells.
Cai T, Lei QY, Wang LY, Zha XL.
Biochem Biophys Res Commun. 2000 Aug 2;274(2):519-25.
Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL.
Cancer Res. 2008 Mar 15;68(6):1809-19.
Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.
Lynch MA, Petrel TA, Song H, Knobloch TJ, Casto BC, Ramljak D, Anderson LM, DeGroff V, Stoner GD, Brueggemeier RW, Weghorst CM.
Gene Expr. 2001;9(4-5):157-71.
Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
Wang SE, Wu FY, Shin I, Qu S, Arteaga CL.
Mol Cell Biol. 2005 Jun;25(11):4703-15.
Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells.
Takeuchi Y, Suzawa M, Kikuchi T, Nishida E, Fujita T, Matsumoto T.
J Biol Chem. 1997 Nov 14;272(46):29309-16.
The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA, Parvani JG, Schiemann WP.
J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. Epub 2010 May 15. Review.
Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim DK, Morrell NW.
Circulation. 2009 Feb 3;119(4):566-76. Epub 2009 Jan 19.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on